These data provide genetic and biochemical evidence indicating that loss of function of Gata3 in mammary tumor cells activates Fosl1 to promote mesenchymal traits and CSC function and concurrently represses Fos to lose epithelial features. This evidence concerns the gene FOSL1 and breast cancer.